Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02XCE
|
||||
Former ID |
DNC003094
|
||||
Drug Name |
S-Oxy Cysteine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551391] | ||
Structure |
Download2D MOL |
||||
Formula |
C3H7NO3S
|
||||
Canonical SMILES |
C(C(C(=O)O)N)S=O
|
||||
InChI |
1S/C3H7NO3S/c4-2(1-8-7)3(5)6/h2,8H,1,4H2,(H,5,6)/t2-/m0/s1
|
||||
InChIKey |
BHLMCOCHAVMHLD-REOHCLBHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Superoxide dismutase [Cu-Zn] | Target Info | Inhibitor | [551391] | |
Prolyl endopeptidase | Target Info | Inhibitor | [551391] | ||
BioCyc Pathway | Reactive oxygen species degradation | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Vasopressin synthesis | ||||
Pathway Interaction Database | Validated nuclear estrogen receptor alpha network | ||||
FOXA1 transcription factor network | |||||
PathWhiz Pathway | Degradation of Superoxides | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.